Tenderwize
Zurück zur Suche

Open House Originale Propranolol Oral Solution

Techniker Krankenkasse·Hamburg, Germany·Deadline Dec 30, 2027 · 493 days left·Open·Supplies
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)

62/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Warum diese Bewertung?

Chance

62 / 100

Komplexität

58 / 100

Risikofaktoren

The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...

Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Supply of pharmaceutical products, specifically Propranolol in oral solution form.
  • Open-house contract model with uniform conditions and no individual negotiations.
Vollständige Zusammenfassung anzeigen

This is an open-house style supply arrangement for Propranolol oral solution in Germany, led by Techniker Krankenkasse with hkk and HEK as participating buyers. The notice states that all suitable pharmaceutical companies may join during the contract period under uniform conditions, with no exclusivity and no individual negotiations. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the participation documents are only available electronically via the buyer portal. The extracted documents were analyzed, but the actual participation/contract documents themselves were not provided.

Risiken

The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...

Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant product.
  • Applicant must have its seat in Germany, another EU Member State, or an EEA state.
  • Applicant must hold a valid marketing authorization for the relevant medicinal product, or otherwise be entitled to place it on the market in its own name.

Auftraggeber

Ort

Hamburg, DEU

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001

Open House Originale Propranolol Oral Solution

Supply arrangement for Propranolol in oral solution form. The lot is described as a nationwide open-house contract under § 130c SGB V, with uniform terms for all eligible pharmaceutical companies. The extracted notice text indicates that participation documents are only provided to companies that market, or can credibly demonstrate they will market, the relevant medicinal product during the contract period.

SuppliesEU fundedElectronic submission

Ort

DE600, Germany

Dauer

Dec 2025 - Dec 2027

Kategorie

Pharmaceutical products

Frist

Deadline Dec 30, 2027

Vergabedetails

Veröffentlichungsdatum
19 Oct 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
689646-2025

Dokumente (1)

Vergabedokument 1

Ähnliche Ausschreibungen

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3